These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 14569172)

  • 21. The role of Tc-99m (V) DMSA scintigraphy in the evaluation of superscan on bone scintigraphy.
    Yüksel D; Ilgan S; Arslan N; Uğur O; Oztürk E; Bayhan H
    Clin Nucl Med; 2000 Mar; 25(3):193-6. PubMed ID: 10698416
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biokinetics and dosimetric studies about 99mTc(V)-DMSA distribution.
    Correia MB; Magnata SS; Silva IM; Catanho MT; Lima FF
    Cell Mol Biol (Noisy-le-grand); 2010 May; 56(2):1-5. PubMed ID: 20525451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of a DMSA kit for instant preparation of 99mTc(V)-DMSA for tumour and metastasis scintigraphy.
    Chauhan UP; Babbar A; Kashyap R; Prakash R
    Int J Rad Appl Instrum B; 1992 Nov; 19(8):825-30. PubMed ID: 1330991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of metastatic bone disease with pentavalent 99Tc(m)-dimercaptosuccinic acid: a comparison with whole-body scanning and 4/24 hour quantitation of vertebral lesions.
    Sahin M; Basoglu T; Bernay I; Yapici O; Canbaz F; Yalin T
    Nucl Med Commun; 2000 Mar; 21(3):251-8. PubMed ID: 10823327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of Tc-99m(V) DMSA for imaging inflammatory lesions: an experimental study.
    Ercan MT; Gülaldi NC; Unsal IS; Aydin M; Peksoy I; Hasçelik Z
    Ann Nucl Med; 1996 Nov; 10(4):419-23. PubMed ID: 9006727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pentavalent technetium-99m-dimercaptosuccinic acid scintigraphy in renal osteodystrophy.
    Higuchi T; Hirano T; Inoue T; Aoki J; Ueki K; Wakamatsu R; Yano S; Naruse T; Endo K
    J Nucl Med; 1998 Mar; 39(3):541-3. PubMed ID: 9529307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paper chromatographic and paper elettrophoretic study of the solution chemistry of Tc-99m-methylendiphosphonate and of Tc-99m-dimercaptosuccinate for improving the tumour-affinity of Tc-99m during scintigraphic imaging of cancer.
    Shukla SK; Atzei G; Sedda AF; Rossi G; Cipriani C
    Ann Chim; 2004; 94(9-10):761-6. PubMed ID: 15506627
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Study on tumor affinity of technetium-99m-labeled radiopharmaceuticals. (2) 99mTc-Sn-diphosphonate (99mTc-EHDP), 99mTc-Sn-dimercaptosuccinic acid (99mTc-DMSA), and 99mTc-Sn-diethyl stilbestrol diphosphate (99mTc-DSDP)].
    Ito K; Kobayashi S; Hisada K; Tonami N; Ando A
    Radioisotopes; 1976 Oct; 25(10):622-9. PubMed ID: 1037404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone-scan-like pattern with 99Tcm(V)-DMSA scintigraphy in patients with osteomalacia and primary hyperparathyroidism.
    Akbunar AT; Orhan B; Alper E
    Nucl Med Commun; 2000 Feb; 21(2):181-5. PubMed ID: 10758614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of 99mTc(V)-DMSA, 201Tl and 99mTc-MIBI imaging in the follow-up of patients with medullary carcinoma of the thyroid.
    Ugur O; Kostakğlu L; Güler N; Caner B; Uysal U; Elahi N; Haliloğlu M; Yüksel D; Aras T; Bayhan H; Bekdik C
    Eur J Nucl Med; 1996 Oct; 23(10):1367-71. PubMed ID: 8781142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Study of the toxicological effect of mitomycin C in mice: alteration on the biodistribution of radiopharmaceuticals used for renal evaluations.
    Gomes ML; de Mattos DM; de Souza Freitas R; Bezerra RJ; Bernardo-Filho M
    Hum Exp Toxicol; 2001 Apr; 20(4):193-7. PubMed ID: 11393272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical evaluation of 99mTc(V)-dimercapto succinic acid (DMSA) for imaging medullary carcinoma of thyroid and its metastasis.
    Patel MC; Patel RB; Ramanathan P; Ramamoorthy N; Krishna BA; Sharma SM
    Eur J Nucl Med; 1988; 13(10):507-10. PubMed ID: 2836203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [99mTc(V)-DMSA accumulation in gynecomastia].
    Ohta H
    Kaku Igaku; 1998 Nov; 35(9):877-9. PubMed ID: 9916404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxygen bubbling can improve the labelling of pentavalent technetium-99m dimercaptosuccinic acid.
    Kobayashi H; Suzuki KH; Sakahara H; Yao ZS; Yokoyama A; Konishi J
    Eur J Nucl Med; 1995 Jun; 22(6):559-62. PubMed ID: 7556304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pentavalent Tc-99m dimercaptosuccinic acid imaging of hepatocellular carcinoma.
    Wang SJ; Lin WY; Wey SP; Shen LH; Ting G
    Neoplasma; 1999; 46(4):246-8. PubMed ID: 10613606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analogy between tumor uptake of technetium(V)-99m dimercaptosuccinic acid (DMSA) and technetium-99m-MDP.
    Wulfrank DA; Schelstraete KH; Small F; Fallais CJ
    Clin Nucl Med; 1989 Aug; 14(8):588-93. PubMed ID: 2553315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 99mTc-(V)DMSA scintimammography in the assessment of breast lesions: comparative study with 99mTc-MIBI.
    Papantoniou V; Christodoulidou J; Papadaki E; Valotassiou V; Stipsanelli A; Louvrou A; Lazaris D; Sotiropoulou M; Pampouras G; Keramopoulos A; Michalas S; Zerva C
    Eur J Nucl Med; 2001 Jul; 28(7):923-8. PubMed ID: 11504092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Search for polynuclear pentavalent technetium complex of dimercaptosuccinic acid [Tc(V)-DMS] tumour localization mechanism. I. Medullary thyroid carcinoma animal model.
    Horiuchi K; Yomoda I; Ohta H; Endo K; Yokoyama A
    Eur J Nucl Med; 1991; 18(10):796-800. PubMed ID: 1660401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis, characterization, and biodistribution of oxo complexes of technetium-99m with biguanide and N1-substituted ligands.
    Neves M; Gano L; Ribeiro MJ; Santos AC; Marchi A; Sawas-Dimopolou C; Pedroso de Lima JJ
    Nucl Med Biol; 1999 Jan; 26(1):79-83. PubMed ID: 10096505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of metabolic and receptor imaging in recurrent medullary thyroid carcinoma with histopathological findings.
    Adams S; Baum RP; Hertel A; Schumm-Draeger PM; Usadel KH; Hör G
    Eur J Nucl Med; 1998 Sep; 25(9):1277-83. PubMed ID: 9724377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.